Towards A Foundation Model for Clinical Voice Biomarkers
Elemento, O.; Sigaras, A.; Colonel, J.; Hajirasouliha, I.; Ghosh, S.; Bensoussan, Y.; Bridge2AI-Voice Consortium, ; Rameau, A.
Show abstract
Vocal biomarkers, encompassing voice and speech, have largely been developed for individual conditions in isolation, limiting their generalizability across diseases and recording settings. To address this, we introduce VoiceFM, a contrastive model that learns general-purpose clinical voice representations by aligning audio embeddings with rich clinical metadata. Using the Bridge2AI-Voice dataset (984 primarily English-speaking adult participants, 846 used for training and 138 held out as a temporally separated validation cohort, 40,056 recordings totaling 176 hours across 5 academic medical centers), VoiceFM pairs a fine-tuned Whisper large-v2 encoder with a tabular transformer over 44 clinical features via symmetric InfoNCE loss. Linear probes on frozen VoiceFM embeddings achieve mean AUROC 0.952 +/- 0.005 across five evaluation tasks (control vs disease screening plus four disease categories), significantly outperforming Frozen Whisper (0.926 +/- 0.013, p = 0.013), Frozen HuBERT (0.885 +/- 0.017, p = 0.0009), and the contrastively trained VoiceFM-HuBERT (0.938 +/- 0.006, p = 0.012). On the 138-participant held-out cohort, VoiceFM-Whisper achieves AUROCs of 0.99 for Alzheimer's/dementia/MCI and 0.89 for airway stenosis, demonstrating that the learned representations generalize to participants the model has never seen. VoiceFM representations transfer to three external datasets without retraining and improve few-shot classification. Recording task attribution identifies a small set of speech tasks that match or exceed the full battery's performance, suggesting shorter screening protocols are feasible. Trained predominantly on English audio, VoiceFM transfers without fine-tuning to Spanish-language Parkinson's disease (PD) detection (NeuroVoz, 107 participants, AUROC 0.93 +/- 0.02), with the signal dominated by articulatory rather than phonatory features. A fine-tuned classifier achieves participant-level AUROC 0.87 (sustained 0.85, countdown 0.80) on the mPower smartphone study (585 held-out participants). Together, these results show that contrastive alignment between voice and rich clinical metadata can serve as the basis for a clinical voice foundation model, producing a single set of transferable representations that generalize across diseases, languages, recording conditions, and patients enrolled after model freeze.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Crowdsourcing digital health measures to predict Parkinson's disease severity: the Parkinson's Disease Digital Biomarker DREAM Challenge 93%
- A Machine-Learning Based Objective Measure for ALS Disease Severity 93%
- Few shot learning for phenotype-driven diagnosis of patients with rare genetic diseases 92%
Similar papers in this journal
- A Neural Speech Decoding Framework Leveraging Deep Learning and Speech Synthesis 93%
- Predicting the prevalence of complex genetic diseases from individual genotype profiles using capsule networks 92%
- Parallel hierarchical encoding of linguistic representations in the human auditory cortex and recurrent automatic speech recognition systems 91%
Similar papers in this journal
- Transformer-based deep learning model for the diagnosis of suspected lung cancer in primary care based on electronic health record data 91%
- A growth chart of brain function from infancy to adolescence based on electroencephalography 90%
- Predicting the functional effects of voltage-gated potassium channel missense variants with multi-task learning 89%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.